ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
failure to respond or late response
on 24 Jun 2023
Last Applicant/ Owned by
2000 Sierra Point Parkway
Brisbane
CA
94005
Serial Number
97417578 filed on 18th May 2022
Registration Number
N/A
Correspondent Address
Connie L. Ellerbach
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
LUMVYTA
Pharmaceutical preparations; pharmaceutical preparations for human use; pharmaceutical preparation for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of oncological diseases; pharmaceutical preparations and substances for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfun Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations; pharmaceutical preparations for human use; pharmaceutical preparation for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of oncological diseases; pharmaceutical preparations and substances for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; targeted medical preparations for use in the field of cancer prevention and treatment; medical and veterinary preparations for the delivery of compounds to the body for the treatment and prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Class [044]
Medical, Beauty & Agricultural Services
Medical information services; healthcare services; research, development, and evaluation of pharmaceutical preparations for the prevention and treatment of cancer; laboratory analysis and research of drugs and pharmaceutical products; research and development services in the fields of oncology, immunotherapy, chemotherapy, and combination therapies for the treatment of cancer and tumors; providing medical research information in the fields of oncology, immunotherapy, chemotherapy and combination therapies; scientific advisory services, namely, providing scientific information, advice, and consultancy in the field of cancer treatment; healthcare services, namely, providing cancer treatment information to physicians, health care professionals, and patients; design, development, research, and testing of drugs and pharmaceuticals for the treatment and/or prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medical information services, namely, providing information regarding viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Mark Details
Serial Number
No 97417578
Mark Type
No Service Mark
Attorney Docket Number
No 37942-00070
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 26th Jun 2023 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| 24th Jun 2023 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| 24th Jun 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| 08th Mar 2023 | NON-FINAL ACTION WRITTEN |
| 08th Mar 2023 | NON-FINAL ACTION E-MAILED |
| 08th Mar 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 07th Mar 2023 | ASSIGNED TO EXAMINER |
| 14th Sep 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 14th Sep 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 14th Sep 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |